MedPath

Effects Of Carnosine On Autism

Not Applicable
Conditions
Autism Disorder.
autism disorders
Registration Number
IRCT2016061711689N4
Lead Sponsor
Deputy Of Research And Technology Of Tabriz University Of Medical Science, Nutritional Science Resea
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

diagnosis of Autism by psychologist; age between 6 to 12 years old; unchanged method of medical treatment since two months before intervention and through out follow up time; not receiving other supplements; mental retardation.
Exclusion criteria: consumption of any types of Chelator drugs in study duration; following of special diet; neurological diseases like epilepsy, Cerebral Palsy and...; all types of metabolic disorders; medical treatment method alteration during study period; adherence of supplement less than 75 percent.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serotonin. Timepoint: at Beginning and eighth week of the study. Method of measurement: ELISA.;Glutamat. Timepoint: at Beginning and eighth week of the study. Method of measurement: HPLC.;Autism disorder severity. Timepoint: At Beginning and eighth week of the study. Method of measurement: GARS questionnaire.;Gastrointestinal disorders. Timepoint: At Beginning and eighth week of the study. Method of measurement: ROME3 questionnaire.;Sleep disorders. Timepoint: At Beginning and eighth week of the study. Method of measurement: CSHQ questionnaire.;Food intake. Timepoint: At Beginning and fourth week and eighth week of the study. Method of measurement: 3 days food intake.
Secondary Outcome Measures
NameTimeMethod
Phisical activity. Timepoint: At Beginning and eighth week of the study. Method of measurement: international phisical activity questionnaire.
© Copyright 2025. All Rights Reserved by MedPath